Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2017.159 | Creating a Novel Topical Agent of Herbal Origin for Atopic Dermatitis through Evidence-Based Research Procedures |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2016.267 | Acceptability and efficacy of topical and systemic treatment in childhood-onset Atopic Dermatitis |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2015.676 | A survey on quality of life and asthma control in Hong Kong, Macau and Shenzhen |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2021.377 | Interdependent Quality of Life in Parent-Child Dyads Adjusting to Eczema: Effects of a Randomized Controlled Trial of the Integrative Body-Mind-Spirit Group Intervention | Prof. HON Ellis Kam Lun |
| 2023.037 | A Phase 3, Multicenter, Randomized, Partially Blinded, Palivizumab- Controlled Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe RSV Disease |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2001.489 | A Randomized, Double-Blind, Placebo-Controlled, Parallel Study of The Therapeutic Effect And Safety Of A Traditional Chinese Medicine (TCM) For Atopic Dermatitis In Children | Prof. HON Ellis Kam Lun |
| 2015.075 | Efficacy and tolerability of a multi-action emollient for childhood atopic eczema: a randomized controlled trial |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2016.018 | Determining regulatory T and B cell dysregulation in childhood atopic eczema |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2017.361 | Double-blind, Randomised, Vehicle-controlled, Phase III, Efficacy and Safety Study with 24-month Open-label Follow-up of Oleogel-S10 in Patients with Inherited Epidermolysis Bullosa |
Prof. HON Ellis Kam Lun 韓錦倫醫生 |
| 2016.269 | Microbiota Profile in Allergic Rhinoconjunctivitis |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2015.588 | Treatment of Atopic Dermatitis Complicated with Staphylococcus aureus –Using Tea Bath: A Pilot Study |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2014.414 | Respiratory pathogens in the PICU | Prof. HON Ellis Kam Lun |
| 2016.027 | Topically applied allogeneic umbilical cord lining membrane-derived mesenchymal stem cells (MSCs) secretome for wound healing in moderate-to-severe childhood atopic eczema: A pilot study |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2017.399 | Effect of pine-tar shower on itch and disease severity in moderate-to-severe childhood eczema |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2016.116 | Review of spectrum of paediatric diseases at a teaching hospital |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2016.118 | Epidemiology of patients seen at the pediatric dermatology clinic |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2018.086 | Intestinal dysbiosis in eczema and airway allergies in twins |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2018.105 | Survey on symptomatology of atopic eczema based on Western and Chinese Medicine disciplines in Children attending Paediatric dermatology clinic |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2018.248 | Effect of a topical spray on itch relief in moderate-to-severe childhood eczema |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2018.401 | A survey of stress, anxiety and quality of life in children with chronic and severe illnesses |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2018.249 | Seeing the Invisible – Effectiveness Study on Holistic Intervention for Children with Eczema And their caregivers |
Prof. HON Ellis Kam Lun 韓錦倫 |
| 2012.039 | Effect of antipsychotics on risk of pneumonia and all-cause mortality in elderly patients with dementia: a 1-year retrospective study | Ms Ho_x000D_So Wing Lam_x000D_In Yung |
| 2019.682 | The Prevalence of Bone Density Monitoring and Predictive Factors for Aromatase Inhibitor-related Bone Fractures in Postmenopausal Women with Breast Cancer |
Mr. HO Yuk Nam 何煜南 |
| 2008.270 | An Exploratory Study of the Stresses and Needs of Chinese Parents During the Hospitalization of Their Preterm Infants | Miss Ho Yuen Wah |
| 2008.002 | Functional Significance of Apolipoprotein Gene Polymorphisms | Prof. HO YUAN-YUAN |
| 2015.543 | Equipment Preference of Hong Kong Ambulance in Mountain Rescue |
Mr. HO Yiu Nam 何燿南 |
| 2012.551 | Predicting Vancomycin Trough Concentrations for Increased Trough Targets in Chinese Population: Comparison of Five Approaches | Miss Ho Yan Yan Wendy |
| 2021.573 | Initial Asian experience of the branched E-vita Open NEO in complex aortic pathologies | Dr. HO Yan Kit |
| 2022.114 | Retrospective record review on timing of post adult cardiac surgery and Coronavirus disease 2019 vaccination |
Dr. HO Yan Kit 何殷傑 |
| 2012.133 | A Randomized, Open Label, Multi-National Study of Cabazitaxel At 25 mg/m_ Every 3 Weeks in Combination With Prednisone Compared To Mitoxantrone in Combination With Prednisone in Asian Patients with Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen | Dr HO Wing-Ming |
| 2016.032 | Learning Ultrasound in Critical Care (LUCC) |
Dr. HO Wing Sze 何穎詩 |
| 2015.389 | A Phase Ib/II, Multicentre, Open Label, Randomised Study of BI 836845 in Combination with Enzalutamide, versus Enzalutamide alone, in Metastatic Castration-Resistant Prostate Cancer (CRPC) Following Disease Progression on Docetaxel-Based Chemotherapy and Abiraterone |
Dr. HO Wing Ming 何永明醫生 |
| 2016.343 | A Randomized, Open-Label, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Avelumab (MSB0010718C) in Combination with and/or Following Chemotherapy in Patients with Previously Untreated Epithelial Ovarian Cancer |
Dr. HO Wing Ming 何永明醫生 |
| 2011.461 | Registry of treatment patterns in patients with metastatic castration-resistant prostate cancer (mCRPC) with progression during or after docetaxel-based regimen | Dr. HO Wing Ming |
| 2020.259 | A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination with Durvalumab, Followed by Maintenance Durvalumab with or without Olaparib in Patients with Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E) |
Dr. HO Wing Ming 何永明 |
| 2008.264 | An International Multi-Centre Open Label 2-Arm Phase III Trial of Adjuvant Bevacizumab in Triple Negative Breast Cancer | Dr. HO Wing Ming |
| 2011.048 | An Open Label Study of Abiraterone Acetate in Subjects with Metastatic Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy Castration-Resistant Prostate Cancer Who Have Progressed After Taxane-Based Chemotherapy | Dr Ho Wing Ming |
| 2009.412 | An open-label, multicenter phase II study to compare the efficacy and safety of RAD001 as first-line followed by second-line sunitinib versus sunitinib as first-line followed by second-line RAD001 in the treatment of patients with metastatic renal cell carcinoma | Dr. Ho Wing Ming |
| 2008.092 | A Phase II Safety and Efficacy Study with the VEGF Receptor Tyrosine Kinase Inhibitor GW786034 in Patients with Metastatic Urothelial Cancer | Dr HO Wing Ming |
| 2009.386 | A randomized phase III, double-blind, placebo-controlled multicenter trial of Everolimus in combination with Trastuzumab and Paclitaxel, as first line therapy in women with HER2 positive locally advanced or metastatic breast cancer | Dr. HO Wing Ming |
| 2011.049 | A Phase 3, Randomized, Double-Blind Trial of Pegylated Liposomal Doxorubicin (PLD) Plus AMG 386 or Placebo in Women With Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | Dr. HO Wing Ming |
| 2007.471 | A Randomized Phase 2 Trial of Double-Blind, Placebo Controlled AMG 706 in Combination with Paclitaxel, or Open-Label Bevacizumab in Combination with Paclitaxel, as First Line Therapy in Women with HER2 Negative Locally Recurrent or Metastatic Breast Cancer | Dr. HO Wing Ming |
| 2011.177 | A Phase II, single-arm study of orally administered BEZ235 as second-line therapy in patients with advanced or metastatic endometrial carcinoma | Dr HO Wing Ming |
| 2011.523 | A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers | Dr. Ho Wing Ming |
| 2021.496 | A Phase III, Open Label, Randomised, 3-Arm, Multi-Centre Study of Savolitinib plus Durvalumab versus Sunitinib and Durvalumab Monotherapy in Participants with MET Driven, Unresectable and Locally Advanced or Metastatic Papillary Renal Cell Carcinoma (PRCC) (SAMETA) |
Dr. HO Wing Ming 何永明 |
| 2008.567 | Study of neonatal natural killer cell activation through cytokine, bacterial protein and accessory cell stimulations, and comparison with NK cell characteristics from neonates with bacterial infection | Dr Ho Wen Ying |
| 2010.096 | Study of human primary neonatal natural killer cells in response to challenge with lipoteichoic acid, a major constituent of gram-positive bacteria | Dr Ho Wen Ying |
| 2009.464 | A Randomized, Double-Blind, Placebo Controlled Study to evaluate the health benefits of Cordyceps mycelium capsules based on the theory of Traditional Chinese Medicine | Prof. Ho Walter K.K. |
| 2020.598 | A retrospective cohort study to determine predicting factors for progression of Non-tuberculosis mycobacterium pulmonary disease |
Dr HO Tracy Hang Yee 何杏儀 |
| 2023.073 | Effectiveness evaluation of paper-based cognitive training in reducing cognitive decline for outpatients with early stage of dementia | Mr. HO Tak Wai |
Page 155 of 254.